SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
 
REPORT OF FOREIGN PRIVATE ISSUER
 
 
Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934



For the month of May, 2015


AVIVA PLC



(Translation of registrant's name into English)


ST HELEN’S, 1 UNDERSHAFT
LONDON EC3P 3DQ

(Address of principal executive offices)



 
Indicate by check mark whether the registrant files or will file annual reports
under cover Form 20-F or Form 40-F.

 
 
Form 20-F X     Form 40-F


 
 
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.



 
Yes      No X


 
 
If "Yes" is marked, indicate below the file number assigned to the registrant
in connection with Rule 12g3-2(b): 82-


 

 
Start
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
 
News Release
 
Aviva plc
Interim management statement for the three months to 31 March 2015
7 May 2015
 
Aviva plc First Quarter 2015
 
Interim Management Statement
 
Mark Wilson, Group Chief Executive Officer, said:
 
"Aviva's turnaround is on track and ahead of schedule. It's been a busy quarter. We have completed the acquisition of Friends Life and at the same time delivered an improvement in our key metrics. Value of new business is up, our general insurance combined operating ratio has improved and our IFRS book value has grown over the quarter. In the face of unpredictable global markets, we continue to improve the Group's resilience.
 
"Detailed plans to integrate Friends Life are well underway and whilst this is a challenging and complex project, we are confident of timely progress. We expect 2015 to be a year of continued delivery of our turnaround plan."
 
 
The acquisition of Friends Life was completed on 10 April 2015, after the period to which this trading statement applies. Therefore, unless otherwise stated, all numbers outside of the Friends Life section are for Aviva standalone.
 
 
Life insurance
 
· Value of new business (VNB) grew 14%1 to £247 million (1Q14: £224 million)
· UK Life VNB grew 15% to £103 million (1Q14: £89 million), driven by higher equity release and pensions, which more than offset a reduction in annuity VNB
· Europe2 VNB grew 11%1 to £102 million, flat in reported currency
· Asia2 VNB grew 16%1 to £36 million (1Q14: £29 million)
 
 
General insurance
 
· Combined operating ratio (COR) improved to 96.4% (1Q14: 97.7%)
· UK COR of 98.3% (1Q14: 98.6%), Canada COR of 98.1% (1Q14: 102.7%), Europe COR of 89.8% (1Q14: 92.0%)
· GI and health net written premiums up 2%1 to £2,037 million, down 2% in reported currency
· UKGI net written premiums up 1% to £855 million (1Q14: £845 million)
 
 
Cash
 
· Operating capital generation (OCG) £0.5 billion (1Q14: £0.4 billion)
 
 
Balance sheet
 
· IFRS net asset value per share increased 2% to 348p (FY14: 340p)
· Economic capital surplus3 £8.1 billion (FY14: £8.0 billion), coverage ratio 177% (FY14: 178%)
· The acquisition of Friends Life added c.55p to our NAV per share on closure4
· Standalone external leverage ratio 40% of tangible capital (FY14: 41%), 28% on an S&P basis (FY14: 28%). Adjusted for Friends Life, estimated leverage ratios are 36% and 27% respectively on closure, well within our target range
· Holding company liquidity of £1.8 billion at 30 April 2015 including Friends Life
 
 
Friends Life
 
· Friends Life transaction completed on 10 April 2015 and detailed integration plans are being implemented
· Positive corporate benefits net flows of £0.2 billion, corporate benefits AUA 7% higher at £23.6 billion (FY14: £22.0 billion)
· Friends Life VNB declined to £20 million (1Q14: £32 million), driven by the expected decline in retirement income VNB following last year's Budget announcement
 
 
1    On a constant currency basis.
2    Europe excludes Eurovita and CxG and Asia excludes South Korea.
3    The economic capital surplus represents an estimated position. The economic capital requirement is based on Aviva's own internal assessment and capital management policies. The term 'economic capital' does not imply capital
      as required by regulators or other third parties.
4    Based on Aviva's pre-acquisition NAV per share at 31 March 2015 of 348p.
 
 
 
Page 2
 
Key financial metrics
 
Operating capital generation
 
   
3 months 2015
£bn
3 months 2014
£bn
United Kingdom & Ireland Life
  
0.3
0.1
United Kingdom & Ireland General Insurance & Health
  
0.1
0.1
Europe
  
0.1
0.2
Canada
  
-
-
Asia and Other
  
-
-
Total
  
0.5
0.4
 
 
Value of new business
 
 
3 months 2015
£m
3 months 2014
£m
Sterling % change1
 
Constant currency % change1
United Kingdom & Ireland
106
92
14%
15%
France
56
54
3%
15%
Poland2
15
21
(29)%
(22)%
Italy2, Spain2 and Turkey
31
27
17%
28%
Asia2
36
29
21%
16%
Aviva Investors
3
-
-
-
Value of new business - excluding Eurovita, CxG & South Korea
247
223
10%
14%
Eurovita, CxG & South Korea
-
1
-
-
Value of new business
247
224
10%
14%
 
 
General insurance combined operating ratio
 
 
3 months 2015
3 months 2014
Change
United Kingdom & Ireland
98.3%
98.7%
(0.4)pp
Europe
89.8%
92.0%
(2.2)pp
Canada
98.1%
102.7%
(4.6)pp
General insurance combined operating ratio
96.4%
97.7%
(1.3)pp
 
 
Capital position
 
 
31 March 2015
£bn
31 December 2014
£bn
Sterling% change
 
Estimated economic capital surplus3
8.1
8.0
1%
Estimated IGD solvency surplus3
3.0
3.2
(6)%
IFRS net asset value per share
348p
340p
2%
MCEV net asset value per share4
526p
527p
-
 
1    Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
2    Poland includes Lithuania, Italy excludes Eurovita, Spain excludes CxG and Asia excludes South Korea.
3    The economic capital and IGD surpluses represent an estimated position. The economic capital requirement is based on Aviva's own internal assessment and capital management policies. The term 'economic capital' does
      not imply capital as required by regulators or other third parties.
4    In preparing the MCEV information, the directors have done so in accordance with the European Insurance CFO Forum MCEV Principles with the exception of stating held for sale operations at their expected
      fair value, as represented by expected sale proceeds, less cost to sell.
 

 
Page 3
 
Group Chief Executive Officer's report
 
 
Overview
 
In the first quarter of 2015, key metrics have improved. Value of new business (VNB) is up 14%1, the combined operating ratio (COR) has improved 1.3 percentage points and our IFRS net asset value per share is 8p higher at 348p. Our UK general insurance business has grown 1% in a market environment that continues to be competitive. In asset management, our flagship AIMS range of funds now has £1.2 billion under management.
 
The Friends Life acquisition closed on 10 April 2015 and work on implementing our detailed integration plans has begun in earnest. We have already announced the closure of the Friends Life head office in London and in Exeter moved to smaller premises.
 
Despite lower interest rates and adverse foreign currency developments, our economic capital surplus3 has remained broadly constant at £8.1 billion (FY14: £8.0 billion) with a coverage ratio of 177% (FY14: 178%). We continue to work closely with our regulators ahead of Solvency II implementation and our long-standing focus on managing the Group using economic capital helps the transition.
 
Our strategy of building a true customer composite, growing our digital business, improving our efficiency, integrating Friends Life and implementing Solvency II leaves no room for complacency.
 
 
Cash
 
Operating capital generation (OCG) has increased to £0.5 billion in the first quarter of 2015 (1Q14: £0.4 billion), driven primarily by UK and Ireland Life, which benefitted from a one-off Pillar One capital release from the transfer of our Irish life business to the UK. We plan to replace OCG with a more relevant measure of capital generation once Solvency II is fully implemented.
 
 
Life insurance
 
· Value of new business
    up 14% in constant currency
 
· UK Life VNB 15% higher driven
   by strong equity release
 
 
Value of new business, our growth measure for life insurance, increased 14% in constant currency to £247 million (1Q14: £224 million).
 
UK Life, the largest contributor to VNB, grew 15% to £103 million, driven by a combination of strong equity release and pensions. Protection VNB was broadly flat and annuities VNB was down 60%, following last year's Budget changes. Platform assets under administration have increased 19% to £6.3 billion (FY14: £5.3 billion) with £0.8 billion of positive net fund flows. Pension freedom began on 6 April 2015 and our front line staff were well prepared for the increased volume of enquiries.
 
Performance in our growth markets of Poland, Turkey and Asia was more subdued in the first quarter although underlying trends remain attractive. Poland2 VNB was 22%1 lower at £15 million (1Q14: £21 million) due to the non-repeat of an £8 million benefit to VNB in 2014 from pension regulatory change in Lithuania, whose financial reporting is incorporated into Poland. Excluding this, Polish2 VNB grew 24%1. In Turkey, VNB grew 4%1 to £6 million (1Q14: £6 million) as the impact of underlying growth was partially offset by a reduction in our share of the business following the partial IPO. Asia2 grew 16%1 as strong performances in China and Singapore were partly offset by India.
 
In our developed European markets, France VNB grew 15%1 to £56 million (1Q14: £54 million), principally due to a shift to higher margin protection and unit-linked savings business, which together now make up 80% of VNB (1Q14: 72%). Italy2 continued its turnaround, with 44%1 growth in VNB to £19 million (1Q14: £15 million), mostly driven by a re-price of our traditional savings product offering. Spain2 and Ireland grew 14%1 and 1%1 respectively, albeit from low bases.
 
We exercised financial discipline in our approach to renew our DBS bancassurance agreement which will expire at the end of 2015. Aviva will retain the existing book of business, associated profits and customer rights and relationships which were purchased in the original transaction with DBS in 2001.
 
 
1    On a constant currency basis.
2    Poland includes Lithuania, Italy excludes Eurovita, Spain excludes CxG and Asia excludes South Korea.
3    The economic capital surplus represents an estimated position. The economic capital requirement is based on Aviva's own internal assessment and capital management policies. The term 'economic capital' does not imply capital as   required by regulators or other third parties.
 



Page 4
 
 
 
General insurance
 
· COR improved 1.3pp to 96.4%
 
· GI and health net written premiums
   2% higher in constant currency
 
 
Our general insurance combined operating ratio (COR) improved 1.3 percentage points to 96.4% (1Q14: 97.7%) due to an improved expense ratio and lower weather losses. Favourable reserve development improved the underlying COR by 0.7 percentage points (1Q14: 1.5pp). General insurance and health net written premiums were 2% higher in constant currency at £2,037 million.
 
The UK COR improved 0.3 percentage points to 98.3% (1Q14: 98.6%). Net written premiums grew 1% in the quarter, in a market rating environment that continues to be competitive.
 
In Canada, the COR improved 4.6 percentage points to 98.1% (1Q14: 102.7%) reflecting better overall weather experience, albeit claims frequency remained above long term average. Net written premiums are 1%1 lower mainly due to selected exits from unprofitable business lines.
 
The European COR improved to 89.8% (1Q14: 92.0%) through a combination of better weather in France and a lower expense ratio across all markets. General insurance and health net written premiums grew 2%1 to £488 million (1Q14: £534 million).  
 
 
Asset Management
 
· AIMS now has
   £1.2 billion of FUM
 
 
The turnaround in our asset management business continues. Gross sales of £1.6 billion are encouraging but we have to see the level of redemptions fall. We have introduced a proactive retention programme to retain and grow key funds. The AIMS flagship range of funds now has £1.2 billion of funds under management and performance is strong, with the AIMS Target Return Fund up 9% in the first 9 months after launch. Work is underway to build distribution through Virtus Investment Partners in the United States and we are actively working towards securing more international agreements.
 
We have already transferred c.£20 billion of funds that were directly managed by Friends Life Group to Aviva Investors. Preparations to receive Friends Life funds managed by external parties are underway.
 
 
Friends Life
 
· Growth in protection
   VNB and corporate
   benefits FUM
   
 
In the first quarter, Friends Life value of new business declined to £20 million (1Q14: £32 million) driven principally by a decline in retirement income VNB, following last year's Budget changes regarding annuities. Protection VNB grew 6% and Friends Life had positive net fund flows in corporate benefits.
 
Corporate benefits funds under management have increased 7% over the quarter to £23.6 billion (FY14: £22.0 billion) following £0.2 billion of net inflows and £1.4 billion of positive net market movements. International VNB reduced to £2 million (1Q14: £3 million).
 
 
Balance Sheet
 
· Economic capital surplus3 resilient
   at £8.1 billion (FY14: £8.0 billion)
 
· IFRS NAV per share up 8p  to 348p
 
 
A resilient capital base is important for our cash flow plus growth thesis. At the end of the first quarter of 2015, our economic capital surplus3 was £0.1 billion higher at £8.1 billion (FY14: £8.0 billion), a coverage ratio of 177% (FY14: 178%). Our relatively low risk portfolio of businesses and active hedging programme meant that interest rate and currency movements experienced in the first quarter had little impact on our economic capital surplus.
 
Our IFRS book value per share increased 2% over the quarter to 348p per share (FY14: 340p). Operating profits, positive investment variances and a small gain in our pension surplus more than offset the negative impact of foreign exchange movements. The acquisition of Friends Life adds c.55p to our Group IFRS book value per share on closure4.
 
The increase in our IFRS book value has brought down our debt leverage to 40% of tangible book value (FY14: 41%), and our S&P leverage ratio is 28% (FY14: 28%). On closure, we expect the Friends Life acquisition to reduce both of these ratios by 4 and 1 percentage points respectively. Our external leverage is now within our target range.
 
 
1    On a constant currency basis.
3    The economic capital surplus represents an estimated position. The economic capital requirement is based on Aviva's own internal assessment and capital management policies. The term 'economic capital' does not imply capital
  as required by regulators or other third parties.
4    Based on Aviva's pre-acquisition NAV per share at 31 March 2015 of 348p.
 

 
Page 5
 
 
Solvency II
 
 
The European insurance industry will adopt Solvency II on 1 January 2016. We anticipate publishing our 2015 Solvency II capital position at our preliminary results in March next year. Our current reported economic capital surplus and composition may differ under Solvency II from the current regulatory regime, including the use of transitional measures on our back book.
 
Good progress has been made on the implementation of Solvency II and we continue to work closely with our regulators prior to formal application for partial internal model approval in June 2015. As previously communicated, we will adopt a standard formula basis for Friends Life initially, transitioning to our internal model over time.
 
We are managing the Group taking into account our current understanding of how the Solvency II rules are likely to apply, albeit there remains uncertainty regarding the final outcome. Our long-standing focus on managing the Group using economic capital helps the transition.
 
Outlook
 
We have had an acceptable start to 2015 with key metrics moving in the right direction. With completion of the Friends Life acquisition, we now have the opportunity to execute on our detailed integration plans. In the other parts of the Group that are not impacted by the integration, our focus is on improving cash flow and growth.
 
The Group is well positioned to deal with the macro, market and regulatory headwinds that face the sector and I am confident that 2015 will see continued progress.
 
 
 Page 6
 
 
 
Notes to editors
All comparators are for the 3 months to 31 March 2014 unless otherwise stated.
      Income and expenses of foreign entities are translated at average exchange rates while their assets and liabilities are translated at the closing rates on 31 March 2015. The average rates employed in this announcement are 1 euro = £0.74 (3 months to 31 March 2014: 1 euro = £0.83) and CAD$1 = £0.53 (3 months to 31 March 2014: CAD$1 = £0.55).
      Growth rates in the press release have been provided in sterling terms unless stated otherwise. The following supplement presents this information on both a sterling and constant currency basis.      
 
Cautionary statements:
This should be read in conjunction with the documents filed by Aviva plc (the "Company" or "Aviva") with the United States Securities and Exchange Commission ("SEC"). This announcement contains, and we may make other verbal or written "forward-looking statements" with respect to certain of Aviva's plans and current goals and expectations relating to future financial condition, performance, results, strategic initiatives and objectives. Statements containing the words "believes", "intends", "expects", "projects", "plans", "will," "seeks", "aims", "may", "could", "outlook", "likely", "target", "goal", "guidance", "trends", "future", "estimates", "potential" and "anticipates", and words of similar meaning, are forward-looking. By their nature, all forward-looking statements involve risk and uncertainty. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in these statements. Aviva believes factors that could cause actual results to differ materially from those indicated in forward-looking statements in the announcement include, but are not limited to: the impact of ongoing difficult conditions in the global financial markets and the economy generally; the impact of simplifying our operating structure and activities; the impact of various local political, regulatory and economic conditions; market developments and government actions regarding the sovereign debt crisis in Europe; the effect of credit spread volatility on the net unrealised value of the investment portfolio; the effect of losses due to defaults by counterparties, including potential sovereign debt defaults or restructurings, on the value of our investments; changes in interest rates that may cause policyholders to surrender their contracts, reduce the value of our portfolio and impact our asset and liability matching; the impact of changes in short or long term inflation; the impact of changes in equity or property prices on our investment portfolio; fluctuations in currency exchange rates; the effect of market fluctuations on the value of options and guarantees embedded in some of our life insurance products and the value of the assets backing their reserves; the amount of allowances and impairments taken on our investments; the effect of adverse capital and credit market conditions on our ability to meet liquidity needs and our access to capital; changes in, or restrictions on, our ability to initiate capital management initiatives or an acceleration of repayment of intercompany indebtedness; changes in or inaccuracy of assumptions in pricing and reserving for insurance business (particularly with regard to mortality and morbidity trends, lapse rates and policy renewal rates), longevity and endowments; a cyclical downturn of the insurance industry; the impact of natural and man-made catastrophic events on our business activities and results of operations; our reliance on information and technology and third-party service providers for our operations and systems; the inability of reinsurers to meet obligations or unavailability of reinsurance coverage; increased competition in the UK and in other countries where we have significant operations; the effect of the European Union's "Solvency II" rules on our regulatory capital requirements; the impact of actual experience differing from estimates used in valuing and amortising deferred acquisition costs ("DAC") and acquired value of in-force business ("AVIF"); the impact of recognising an impairment of our goodwill or intangibles with indefinite lives; changes in valuation methodologies, estimates and assumptions used in the valuation of investment securities; the effect of legal proceedings and regulatory investigations; the impact of operational risks, including inadequate or failed internal and external processes, systems and human error or from external events; risks associated with arrangements with third parties, including joint ventures; our reliance on third-party distribution channels to deliver our products; funding risks associated with our participation in defined benefit staff pension schemes; the failure to attract or retain the necessary key personnel; the effect of systems errors or regulatory changes on the calculation of unit prices or deduction of charges for our unit-linked products that may require retrospective compensation to our customers; the effect of fluctuations in share price as a result of general market conditions or otherwise; the effect of simplifying our operating structure and activities; the effect of a decline in any of our ratings by rating agencies on our standing among customers, broker-dealers, agents, wholesalers and other distributors of our products and services; changes to our brand and reputation; changes in government regulations or tax laws in jurisdictions where we conduct business, including decreased demand for annuities in the UK due to proposed changes in UK law; the inability to protect our intellectual property; the effect of undisclosed liabilities, integration issues and other risks associated with our acquisitions; and the timing/regulatory approval impact, integration risk and other uncertainties, such as non-realisation of expected benefits or diversion of management attention and other resources, relating to announced acquisitions and pending disposals and relating to future acquisitions, combinations or disposals within relevant industries, including specifically the acquisition of Friends Life; the policies, decisions and actions of government or regulatory authorities in the UK, the EU, the US or elsewhere, including the implementation of key legislation and regulation. For a more detailed description of these risks, uncertainties and other factors, please see Item 3d, "Risk Factors", and Item 5, "Operating and Financial Review and Prospects" in Aviva's most recent Annual Report on Form 20-F as filed with the SEC on 16 March 2015 and also the risk factors contained in the Euro Note Programme prospectus published on 1 May 2015. Aviva undertakes no obligation to update the forward looking statements in this announcement or any other forward-looking statements we may make. Forward-looking statements in this presentation are current only as of the date on which such statements are made.
 
Aviva plc is a company registered in England No. 2468686.
Registered office
St Helen's
1 Undershaft
London
EC3P 3DQ
 

 
Contacts
 
Investor contacts
Media contacts
Timings
Colin Simpson
+44 (0)20 7662 8115
 
David Elliot
+44 (0)20 7662 8048
Nigel Prideaux
+44 (0)20 7662 0215
 
Andrew Reid
+44 (0)20 7662 3131
 
Sarah Swailes
+44 (0)20 7662 6700
Real time media conference call: 08:30 hrs BST
 
Analyst conference call: 10:00 hrs BST
Tel: +44(0)20 3427 1903
Conference ID: 8626356
 
 
 
Page 7
 
Statistical Supplement
 
In this section:
 
 
A.   Aviva plc - Statistical Supplement
 
B.   Friends Life Group Limited - Statistical Supplement
 
 
Page 8
 
 
A. Aviva plc - Statistical Supplement
 
A1.             Basis of preparation    
 
A2.            Trend analysis of VNB - cumulative
 
A3.             Trend analysis of VNB - discrete
 
A4.             Trend analysis of PVNBP - cumulative
 
A5.             Trend analysis of PVNBP - discrete
 
A6.             Trend analysis of PVNBP by product - cumulative
 
A7.             Trend analysis of PVNBP by product - discrete
 
A8.             Geographical analysis of regular and single premiums
 
A9.             Trend analysis of Investment sales - cumulative
 
A10.     Trend analysis of Investment sales - discrete
 
A11.     Geographical analysis of regular and single premiums - investment sales
 
A12.     Trend analysis of general insurance and health net written premiums - cumulative
 
A13.     Trend analysis of general insurance and health net written premiums - discrete
 
Page 9
 
A1 - Basis of preparation
 
Given that the acquisition of Friends Life Group Limited ("Friends Life") by Aviva plc ("Aviva") did not complete until 10 April 2015, unless otherwise stated the information included in this announcement and Part A of the statistical supplement excludes Friends Life's results for the three months ended 31 March 2015 and does not include the effect of the acquisition of Friends Life.
 
Part B of the statistical supplement sets out Friends Life's VNB, PVNBP, APE and assets under administration for the three months ended 31 March 2015, prior to the acquisition of Friends Life by Aviva. For the avoidance of doubt this information is presented unadjusted on Friends Life's basis prior to acquisition by Aviva. The reporting basis will be adjusted to align with Aviva for future reporting.
 
A2 - Trend analysis of VNB - cumulative
 
             
Growth1 on 1Q14
Gross of tax and non-controlling interests
1Q14 YTD
£m
2Q14 YTD
£m
3Q14 YTD
£m
4Q14 YTD
£m
1Q15 YTD
£m
Sterling
%
Constant currency
%
United Kingdom
89
177
297
473
103
15%
15%
Ireland
3
6
6
9
3
(10)%
1%
United Kingdom & Ireland
92
183
303
482
106
14%
15%
France
54
110
156
205
56
3%
15%
Poland2
21
34
46
64
15
(29)%
(22)%
Italy - excluding Eurovita
15
26
41
63
19
29%
44%
Spain - excluding CxG
6
14
19
30
6
2%
14%
Turkey
6
14
23
30
6
2%
4%
Europe
102
198
285
392
102
-
11%
Asia - excluding South Korea
29
61
92
122
36
21%
16%
Aviva Investors3
-
2
5
9
3
-
-
Value of new business - excluding Eurovita, CxG & South Korea
223
444
685
1,005
247
10%
14%
Eurovita, CxG & South Korea
1
-
1
4
-
-
-
Total value of new business
224
444
686
1,009
247
10%
14%
 
1    Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
2    Poland includes Lithuania.
3    The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
 
A3 - Trend analysis of VNB - discrete
 
             
Growth1 on 1Q14
Gross of tax and non-controlling interests
1Q14 Discrete
£m
2Q14 Discrete
£m
3Q14 Discrete
£m
4Q14 Discrete
£m
1Q15 Discrete
£m
Sterling
%
Constant currency
%
United Kingdom
89
88
120
176
103
15%
15%
Ireland
3
3
-
3
3
(10)%
1%
United Kingdom & Ireland
92
91
120
179
106
14%
15%
France
54
56
46
49
56
3%
15%
Poland2
21
13
12
18
15
(29)%
(22)%
Italy - excluding Eurovita
15
11
15
22
19
29%
44%
Spain - excluding CxG
6
8
5
11
6
2%
14%
Turkey
6
8
9
7
6
2%
4%
Europe
102
96
87
107
102
-
11%
Asia - excluding South Korea
29
32
31
30
36
21%
16%
Aviva Investors3
-
2
3
4
3
-
-
Value of new business - excluding Eurovita, CxG & South Korea
223
221
241
320
247
10%
14%
Eurovita, CxG & South Korea
1
(1)
1
3
-
-
-
Total value of new business
224
220
242
323
247
10%
14%
 
1    Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
2    Poland includes Lithuania.
3    The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
 
 
Page 10
 
A4 - Trend analysis of PVNBP - cumulative
 
             
Growth2 on 1Q14
Present value of new business premiums1
1Q14 YTD
£m
2Q14 YTD
£m
3Q14 YTD
£m
4Q14 YTD
£m
1Q15 YTD
£m
Sterling
%
Constant currency
%
United Kingdom
2,931
6,052
9,098
12,009
2,445
(17)%
(17)%
Ireland
105
196
291
435
132
25%
39%
United Kingdom & Ireland
3,036
6,248
9,389
12,444
2,577
(15)%
(15)%
France
1,310
2,427
3,538
4,633
1,319
1%
12%
Poland3
234
332
429
573
110
(53)%
(48)%
Italy - excluding Eurovita
698
1,440
2,060
2,473
603
(14)%
(4)%
Spain - excluding CxG
270
536
743
1,054
224
(17)%
(8)%
Turkey
110
231
348
495
134
21%
25%
Europe
2,622
4,966
7,118
9,228
2,390
(9)%
1%
Asia - excluding South Korea
421
867
1,357
1,854
623
48%
43%
Aviva Investors4
5
257
562
881
366
-
-
Total - excluding Eurovita, CxG & South Korea
6,084
12,338
18,426
24,407
5,956
(2)%
2%
Eurovita, CxG & South Korea
136
292
307
321
-
-
-
Total
6,220
12,630
18,733
24,728
5,956
(4)%
-
 
1    Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
2    Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3    Poland includes Lithuania.
4    The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
 
 
A5 - Trend analysis of PVNBP - discrete
             
Growth2 on 1Q14
Present value of new business premiums1
1Q14 Discrete
£m
2Q14 Discrete
£m
3Q14 Discrete
£m
4Q14 Discrete
£m
1Q15 Discrete
£m
Sterling
%
Constant currency
%
United Kingdom
2,931
3,121
3,046
2,911
2,445
(17)%
(17)%
Ireland
105
91
95
144
132
25%
39%
United Kingdom & Ireland
3,036
3,212
3,141
3,055
2,577
(15)%
(15)%
France
1,310
1,117
1,111
1,095
1,319
1%
12%
Poland3
234
98
97
144
110
(53)%
(48)%
Italy - excluding Eurovita
698
742
620
413
603
(14)%
(4)%
Spain - excluding CxG
270
266
207
311
224
(17)%
(8)%
Turkey
110
121
117
147
134
21%
25%
Europe
2,622
2,344
2,152
2,110
2,390
(9)%
1%
Asia - excluding South Korea
421
446
490
497
623
48%
43%
Aviva Investors4
5
252
305
319
366
-
-
Total - excluding Eurovita, CxG & South Korea
6,084
6,254
6,088
5,981
5,956
(2)%
2%
Eurovita, CxG & South Korea
136
156
15
14
-
-
-
Total
6,220
6,410
6,103
5,995
5,956
(4)%
-
 
1    Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
2    Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3    Poland includes Lithuania.
4    The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
 
 
Page 11
 
A6 - Trend analysis of PVNBP by product - cumulative
 
             
Growth2 on 1Q14
Present value of new business premiums1
1Q14 YTD
£m
2Q14 YTD
£m
3Q14 YTD
£m
4Q14 YTD
£m
1Q15 YTD
£m
Sterling
%
Constant currency
%
Pensions
1,328
2,794
4,081
5,803
1,319
(1)%
(1)%
Annuities
500
935
1,656
1,948
136
(73)%
(73)%
Bonds
45
87
135
174
39
(12)%
(12)%
Protection
297
568
862
1,103
268
(10)%
(10)%
Equity release
117
257
462
696
206
76%
76%
Other3
644
1,411
1,902
2,285
477
(26)%
(26)%
United Kingdom
2,931
6,052
9,098
12,009
2,445
(17)%
(17)%
Ireland
105
196
291
435
132
25%
39%
United Kingdom & Ireland
3,036
6,248
9,389
12,444
2,577
(15)%
(15)%
Savings
1,232
2,278
3,347
4,368
1,224
(1)%
11%
Protection
78
149
191
265
95
22%
36%
France
1,310
2,427
3,538
4,633
1,319
1%
12%
Pensions
302
465
631
904
192
(36)%
(32)%
Savings
890
1,819
2,583
3,182
754
(15)%
(5)%
Annuities
2
2
3
5
-
(91)%
(90)%
Protection
118
253
363
504
125
5%
16%
Poland4, Italy4, Spain4 and Turkey
1,312
2,539
3,580
4,595
1,071
(18)%
(10)%
Europe
2,622
4,966
7,118
9,228
2,390
(9)%
1%
Asia4
421
867
1,357
1,854
623
48%
43%
Aviva Investors5
5
257
562
881
366
-
-
Total - excluding Eurovita, CxG & South Korea
6,084
12,338
18,426
24,407
5,956
(2)%
2%
Eurovita, CxG & South Korea
136
292
307
321
-
-
-
Total
6,220
12,630
18,733
24,728
5,956
(4)%
-
 
1    Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
2    Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3    Other UK business includes UK Retail Fund Management, UK platform collectives and UK long term health business. The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
4    Poland includes Lithuania, Italy excludes Eurovita, Spain excludes CxG and Asia excludes South Korea.
5    The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
 
 
A7 - Trend analysis of PVNBP by product - discrete
 
             
Growth2 on 1Q14
Present value of new business premiums1
1Q14 Discrete
 £m
2Q14 Discrete
£m
3Q14 Discrete
 £m
4Q14 Discrete
£m
1Q15 Discrete
£m
Sterling
%
Constant currency
%
Pensions
1,328
1,466
1,287
1,722
1,319
(1)%
(1)%
Annuities
500
435
721
292
136
(73)%
(73)%
Bonds
45
42
48
39
39
(12)%
(12)%
Protection
297
271
294
241
268
(10)%
(10)%
Equity release
117
140
205
234
206
76%
76%
Other3
644
767
491
383
477
(26)%
(26)%
United Kingdom
2,931
3,121
3,046
2,911
2,445
(17)%
(17)%
Ireland
105
91
95
144
132
25%
39%
United Kingdom & Ireland
3,036
3,212
3,141
3,055
2,577
(15)%
(15)%
Savings
1,232
1,046
1,069
1,021
1,224
(1)%
11%
Protection
78
71
42
74
95
22%
36%
France
1,310
1,117
1,111
1,095
1,319
1%
12%
Pensions
302
163
166
273
192
(36)%
(32)%
Savings
890
929
764
599
754
(15)%
(5)%
Annuities
2
-
1
2
-
(91)%
(90)%
Protection
118
135
110
141
125
5%
16%
Poland4, Italy4, Spain4 and Turkey
1,312
1,227
1,041
1,015
1,071
(18)%
(10)%
Europe
2,622
2,344
2,152
2,110
2,390
(9)%
1%
Asia4
421
446
490
497
623
48%
43%
Aviva Investors5
5
252
305
319
366
-
-
Total - excluding Eurovita, CxG & South Korea
6,084
6,254
6,088
5,981
5,956
(2)%
2%
Eurovita, CxG & South Korea
136
156
15
14
-
-
-
Total
6,220
6,410
6,103
5,995
5,956
(4)%
-
 
1    Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
2    Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3    Other UK business includes UK Retail Fund Management, UK platform collectives and UK long term health business. The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
4    Poland includes Lithuania, Italy excludes Eurovita, Spain excludes CxG and Asia excludes South Korea.
5    The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
 
 
Page 12
 
A8 - Geographical analysis of regular and single premiums
 
             
Regular premiums
    
Single premiums
 
 3 months 2015
£m
Constant currency growth1
WACF
 
 
Present value
£m
 
3 months 2014
£m
 
WACF
 
 
Present value
£m
 
3 months 2015
£m
 3 months 2014
£m
 
Constant currency growth1
United Kingdom
206
(15)%
5.6
1,158
243
5.0
1,203
1,287
1,728
(26)%
Ireland
6
9%
6.5
39
7
4.6
32
93
73
42%
United Kingdom & Ireland
212
(15)%
5.6
1,197
250
4.9
1,235
1,380
1,801
(23)%
France
24
3%
9.2
221
26
7.8
202
1,098
1,108
11%
Poland2
10
(42)%
7.5
75
19
10.7
204
35
30
28%
Italy - excluding Eurovita
4
(75)%
6.8
27
19
5.0
95
576
603
7%
Spain - excluding CxG
9
(1)%
6.1
55
10
5.2
52
169
218
(13)%
Turkey
27
3%
4.1
110
27
3.6
98
24
12
110%
Europe
74
(20)%
6.6
488
101
6.4
651
1,902
1,971
8%
Asia - excluding South Korea
81
43%
6.3
512
54
6.3
340
111
81
33%
Aviva Investors3
-
-
-
-
-
-
-
366
5
-
Total - excluding Eurovita, CxG & South Korea
367
(8)%
6.0
2,197
405
5.5
2,226
3,759
3,858
3%
Eurovita, CxG & South Korea
-
-
-
-
17
3.6
62
-
74
-
Total
367
(12)%
6.0
2,197
422
5.4
2,288
3,759
3,932
1%
 
1    Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
2    Poland includes Lithuania.
3    The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
 
A9 - Trend analysis of Investment sales - cumulative
 
             
Growth2 on 1Q14
Investment sales1
1Q14 YTD
£m
2Q14 YTD
£m
3Q14 YTD
£m
4Q14 YTD
£m
1Q15 YTD
£m
Sterling
%
Constant currency
%
United Kingdom & Ireland3
486
1,043
1,405
1,742
271
(44)%
(44)%
Aviva Investors4
730
1,616
2,195
3,089
1,073
47%
61%
Asia
36
75
110
146
41
17%
14%
Total investment sales
1,252
2,734
3,710
4,977
1,385
11%
16%
 
1    Investment sales are calculated as new single premiums plus the annualised value of new regular premiums.
2    Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3    UK & Ireland investment sales are also reported in UK Life PVNBP following the extension of MCEV covered business. 2014 investment sales are included at the same amount in UK Life 2014 PVNBP. 1Q15 investment sales of
      £271 million are equivalent to £295 million on a PVNBP basis following a change in the capitalisation factor of regular premiums.
4    The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014. YTD investment sales of £250 million for 2Q14, £549 million for 3Q14, £864 million for 4Q14 and £362 million for
      1Q15 are also included in Aviva Investors' PVNBP following the extension of MCEV covered business.
 
 
A10 - Trend analysis of Investment sales - discrete
 
             
Growth2 on 1Q14
Investment sales1
1Q14 Discrete
£m
2Q14 Discrete
£m
3Q14 Discrete
£m
4Q14 Discrete
£m
1Q15 Discrete
£m
Sterling
%
Constant currency
%
United Kingdom & Ireland3
486
557
362
337
271
(44)%
(44)%
Aviva Investors4
730
886
579
894
1,073
47%
61%
Asia
36
39
35
36
41
17%
14%
Total investment sales
1,252
1,482
976
1,267
1,385
11%
16%
 
1    Investment sales are calculated as new single premiums plus the annualised value of new regular premiums.
2    Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3    UK & Ireland investment sales are also reported in UK Life PVNBP following the extension of MCEV covered business. 2014 investment sales are included at the same amount in UK Life 2014 PVNBP. 1Q15 investment sales of
      £271 million are equivalent to £295 million on a PVNBP basis following a change in the capitalisation factor of regular premiums.
4    The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014. Discrete investment sales of £250 million for 2Q14, £299 million for 3Q14, £315 million for 4Q14 and £362 million
       for 1Q15 are also included in Aviva Investors' PVNBP following the extension of MCEV covered business.
 
 
A11 - Geographical analysis of regular and single premiums - investment sales
 
     
Regular
    
Single
PVNBP
Investment sales1
 3 months 2015
£m
3 months 2014
£m
 
Constant currency growth2
3 months 2015
£m
 
 3 months 2014
£m
 
Constant currency growth2
Constant currency growth2
United Kingdom & Ireland3
6
5
27%
265
481
(45)%
(44)%
Aviva Investors4
1
2
(1)%
1,072
728
61%
61%
Asia
-
-
-
41
36
14%
14%
Total investment sales
7
7
21%
1,378
1,245
16%
16%
 
1    Investment sales are calculated as new single premiums plus the annualised value of new regular premiums.
2    Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3    UK & Ireland investment sales are also reported in UK Life PVNBP following the extension of MCEV covered business. 2014 investment sales are included at the same amount in UK Life 2014 PVNBP. 1Q15 investment
      sales of £271 million are equivalent to £295 million on a PVNBP basis following a change in the capitalisation factor of regular premiums.
4    The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014. YTD investment sales of £250 million for 2Q14, £549 million for 3Q14, £864 million for 4Q14 and £362 million for
      1Q15 are also included in Aviva Investors' PVNBP following the extension of MCEV covered business.
 
 
Page 13
 
A12 - Trend analysis of general insurance and health net written premiums - cumulative
 
             
Growth1 on 1Q14
 
1Q14 YTD
£m
2Q14 YTD
£m
3Q14 YTD
£m
4Q14 YTD
£m
1Q15 YTD
 £m
Sterling
%
Constant currency
%
General insurance
              
United Kingdom
845
1,836
2,742
3,663
855
1%
1%
Ireland
65
136
205
272
63
(3)%
8%
United Kingdom & Ireland
910
1,972
2,947
3,935
918
1%
2%
Europe
440
747
999
1,313
399
(9)%
1%
Canada
426
1,026
1,584
2,104
409
(4)%
(1)%
Asia
3
7
10
13
3
(17)%
(19)%
Other
4
5
5
7
-
(97)%
(97)%
 
1,783
3,757
5,545
7,372
1,729
(3)%
1%
Health insurance
              
United Kingdom2
144
302
394
518
158
10%
10%
Ireland
33
47
65
93
28
(17)%
(7)%
United Kingdom & Ireland
177
349
459
611
186
5%
7%
Europe
94
138
182
243
89
(5)%
6%
Asia3
29
45
61
74
33
14%
12%
 
300
532
702
928
308
3%
7%
Total
2,083
4,289
6,247
8,300
2,037
(2)%
2%
 
1    Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
2    These premiums are also reported in UK Life PVNBP following the extension of MCEV covered business. 1Q14 NWP of £144 million, 2Q14 YTD NWP of £302 million, 3Q14 YTD NWP of £394 million, 4Q14 YTD NWP of
      £518 million  and 1Q15 NWP of £158 million are respectively equivalent to £158 million, £368 million, £497 million, £543 million and £182 million on a PVNBP basis.
3    Singapore long term health business is also reported in Asia PVNBP following the extension of MCEV covered business. For Singapore long term health business, 1Q14 NWP of £5 million, 2Q14 YTD NWP of
      £9 million, 3Q14 YTD NWP of £15 million, 4Q14 YTD NWP of £22 million and 1Q15 NWP of £10 million are respectively equivalent to £37 million, £87 million, £130 million, £183 million and £48 million on a PVNBP basis.
 
 
A13 - Trend analysis of general insurance and health net written premiums - discrete
 
             
Growth1 on 1Q14
 
1Q14 Discrete
£m
2Q14 Discrete
£m
3Q14 Discrete
£m
4Q14 Discrete
£m
1Q15 Discrete
£m
Sterling
%
Constant currency
%
General insurance
              
United Kingdom
845
991
906
921
855
1%
1%
Ireland
65
71
69
67
63
(3)%
8%
United Kingdom & Ireland
910
1,062
975
988
918
1%
2%
Europe
440
307
252
314
399
(9)%
1%
Canada
426
600
558
520
409
(4)%
(1)%
Asia
3
4
3
3
3
(17)%
(19)%
Other
4
1
-
2
-
(97)%
(97)%
 
1,783
1,974
1,788
1,827
1,729
(3)%
1%
Health insurance
              
United Kingdom2
144
158
92
124
158
10%
10%
Ireland
33
14
18
28
28
(17)%
(7)%
United Kingdom & Ireland
177
172
110
152
186
5%
7%
Europe
94
44
44
61
89
(5)%
6%
Asia3
29
16
16
13
33
14%
12%
 
300
232
170
226
308
3%
7%
Total
2,083
2,206
1,958
2,053
2,037
(2)%
2%
 
1    Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
2    These premiums are also reported in UK Life PVNBP following the extension of MCEV covered business. 1Q14 NWP of £144 million, 2Q14 NWP of £158 million, 3Q14 NWP of £92 million, 4Q14 NWP of £124
      million and 1Q15 NWP of £158 million are respectively equivalent to £158 million, £210 million, £129 million, £46 million and £182 million on a PVNBP basis.
3    Singapore long term health business is also reported in Asia PVNBP following the extension of MCEV covered business. For Singapore long term health business, 1Q14 NWP of £5 million, 2Q14 NWP of £4 million,
      3Q14 NWP of £6 million, 4Q14 NWP of £7 million and 1Q15 NWP of £10 million are respectively equivalent to £37 million, £50 million, £43 million, £53 million and £48 million on a PVNBP basis.
 
 
Page 14
 
 
B.   Friends Life Group Limited - Statistical Supplement
 
B1.       Basis of preparation
 
B2.       Trend analysis of VNB - cumulative
 
B3.       Trend analysis of VNB - discrete
     
B4.       Analysis of VNB by product
 
B5.       Trend analysis of PVNBP - cumulative
 
B6        Trend analysis of PVNBP - discrete
 
B7.       Trend analysis of PVNBP by product - cumulative
 
B8.       Trend analysis of PVNBP by product - discrete
 
B9.       Analysis of APE by product
 
B10.     Analysis of assets under administration
 
Page 15
 
 
B1 - Basis of preparation
 
Part B of the statistical supplement sets out Friends Life's VNB, PVNBP, APE and assets under administration for the three months ended 31 March 2015, prior to the acquisition of Friends Life by Aviva. For the avoidance of doubt this information is presented unadjusted on Friends Life's basis prior to acquisition by Aviva. The reporting basis will be adjusted to align with Aviva for future reporting.
All results are presented excluding Lombard.
 
B2 - Trend analysis of VNB - cumulative
 
             
Growth on
1Q14
Gross of tax and non-controlling interests
1Q14
YTD
£m
2Q14
YTD
£m
3Q14
YTD
£m
4Q14
YTD
£m
1Q15
 YTD
£m
Sterling
%
Constant
currency
%
United Kingdom (including Heritage)
29
60
85
120
18
(38)%
(38)%
International
3
5
9
12
2
(33)%
(57)%
Total value of new business
32
65
94
132
20
(38)%
n/a
 
B3 - Trend analysis of VNB - discrete
 
             
Growth on
1Q14
Gross of tax and non-controlling interests
1Q14
Discrete
£m
2Q14
Discrete
£m
3Q14
Discrete
£m
4Q14
Discrete
£m
1Q15
 Discrete
£m
Sterling
%
Constant
currency
%
United Kingdom (including Heritage)
29
31
25
35
18
(38)%
(38)%
International
3
2
4
3
2
(33)%
(57)%
Total value of new business
32
33
29
38
20
(38)%
n/a
 
B4 - Analysis of VNB by product
 
       
Growth on
1Q14
Gross of tax and non-controlling interests
1Q14
YTD
£m
1Q15
 YTD
£m
Sterling
%
Constant
currency
%
Protection
16
17
6%
6%
Retirement income
15
4
(73)%
(73)%
Corporate benefits
4
3
(25)%
(25)%
United Kingdom (excluding Heritage)
35
24
(31)%
(31)%
Heritage
(6)
(6)
-
-
International
3
2
(33)%
(57)%
Total value of new business
32
20
(38)%
n/a
 
 
 
Page 16
 
 
B5 - Trend analysis of PVNBP - cumulative
 
             
Growth on
1Q14
Present value of new business premiums1
1Q14
YTD
£m
2Q14
YTD
£m
3Q14
YTD
£m
4Q14
YTD
£m
1Q15
 YTD
£m
Sterling
%
Constant
currency
%
United Kingdom (including Heritage)
1,124
2,302
3,276
4,272
880
(22)%
(22)%
International
167
343
580
801
194
16%
12%
Total
1,291
2,645
3,856
5,073
1,074
(17)%
n/a
 
1    Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
 
B6 - Trend analysis of PVNBP - discrete
 
             
Growth on
1Q14
Present value of new business premiums1
1Q14
Discrete
£m
2Q14
Discrete
£m
3Q14
Discrete
£m
4Q14
Discrete
£m
1Q15
 Discrete
£m
Sterling
%
Constant
currency
%
United Kingdom (including Heritage)
1,124
1,178
974
996
880
(22)%
(22)%
International
167
176
237
221
194
16%
12%
Total
1,291
1,354
1,211
1,217
1,074
(17)%
n/a
 
1    Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
 
B7 - Trend analysis of PVNBP by product - cumulative
 
             
Growth on
1Q14
Present value of new business premiums1
1Q14
YTD
£m
2Q14
YTD
£m
3Q14
YTD
£m
4Q14
YTD
£m
1Q15
 YTD
£m
Sterling
%
Constant
currency
%
Protection
173
336
497
638
163
(6)%
(6)%
Retirement income
147
299
440
559
92
(37)%
(37)%
Corporate benefits
741
1,529
2,146
2,817
557
(25)%
(25)%
United Kingdom (excluding Heritage)
1,061
2,164
3,083
4,014
812
(23)%
(23)%
Heritage
63
138
193
258
68
8%
8%
International
167
343
580
801
194
16%
12%
Total
1,291
2,645
3,856
5,073
1,074
(17)%
n/a
 
1    Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
 
B8 - Trend analysis of PVNBP by product - discrete
 
             
Growth on
1Q14
Present value of new business premiums1
1Q14
Discrete
£m
2Q14
Discrete
£m
3Q14
Discrete
£m
4Q14
Discrete
£m
1Q15
Discrete
£m
Sterling
%
Constant
currency
%
Protection
173
163
161
141
163
(6)%
(6)%
Retirement income
147
152
141
119
92
(37)%
(37)%
Corporate benefits
741
788
617
671
557
(25)%
(25)%
United Kingdom (excluding Heritage)
1,061
1,103
919
931
812
(23)%
(23)%
Heritage
63
75
55
65
68
8%
8%
International
167
176
237
221
194
16%
12%
Total
1,291
1,354
1,211
1,217
1,074
(17)%
n/a
 
1    Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
 
 
 
 
Page 17
 
B9 - Analysis of APE by product
 
       
Growth on
1Q14
Annual premium equivalent1
Gross of tax and non-controlling interests
1Q14
YTD
£m
1Q15
 YTD
£m
Sterling
%
Constant
currency
%
Protection
24
19
(21)%
(21)%
Retirement income
15
9
(40)%
(40)%
Corporate benefits
162
121
(25)%
(25)%
United Kingdom (excluding Heritage)
201
149
(26)%
(26)%
Heritage
11
12
9%
9%
International
23
27
17%
10%
Total
235
188
(20)%
n/a
 
1    Annual premium of regular premium contracts plus 10% of single premium contracts.
 
B10 - Analysis of assets under administration
 
Assets under administration (£bn)
1 January
2015
Inflows
Outflows
Net
fund
flows
Net
investment
returns
31 March
2015
Corporate benefits
22.0
0.6
(0.4)
0.2
1.4
23.6
 
 
 
END
 
 
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date 07 May, 2015
 
AVIVA PLC
   
 
By: /s/ K.A. Cooper
   
 
K.A. Cooper
 
Group Company Secretary